Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2022-01-11Clinical Trial Update: Pilot of Mindfulness Oriented Recovery Enhancement in MethadoneTreatment [NA]
A completed pilot clinical trial evaluating Mindfulness Oriented Recovery Enhancement as a treatment in individuals undergoing methadone mai…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment [Phase 2]
Phase 2 trial evaluating lofexidine for managing opioid withdrawal in patients treated with extended-release naltrexone (XR-NTX) has complet…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment [EARLY_Phase 1]
Early-phase clinical trial update on an OTP-pharmacy collaboration for methadone maintenance treatment in opioid-use disorder; trial complet…
-
FDA approval · 2021-11-24FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for buprenorphine from Hikma Pharmaceuticals USA Inc., granting approval for this generic produc…
-
FDA approval · 2021-11-24FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for buprenorphine and naloxone from Lannett Company, Inc., confirming the availability of this gener…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-11-19FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
The FDA approved a supplemental application for Suboxone (buprenorphine/naloxone) submitted by Indivior Inc.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Prevention of Persistent Opioid Use in Mothers [Phase 4]
Phase 4 trial reporting results on preventing persistent opioid use in postpartum mothers; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: 24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery [NA]
Completed trial evaluating 24-hour morphine-equivalent-based opioid prescribing after surgery; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans [Phase 2]
Phase 2 clinical trial update assessing how the A118G SNP in the OPRM1 gene influences opioid sensitivity and abuse-related effects in human…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants [Phase 1]
Phase 1 study assessing safety, tolerability and pharmacokinetics of multiple doses of ASP8062 with a single morphine dose in recreational o…
-
FDA approval · 2021-09-23FDA Approved: BUPRENORPHINE — Original Application (INGENUS PHARMACEUTICALS, LLC)
FDA approved a generic buprenorphine product from Ingenus Pharmaceuticals under the original ANDA application (ANDA210272).
-
FDA approval · 2021-09-13FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methadose (methadone hydrochloride) submitted by SpecGx LLC.
-
FDA approval · 2021-08-23FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Buprenorphine and Naloxone from Sun Pharmaceutical Industries, Inc., updating the product's …
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder [Phase 2]
Phase 2 clinical trial update for a computerized chemosensory-based orbitofrontal cortex intervention targeting opioid use disorder; current…
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: Feasibility and Validation of a Standard Phenotyping Assessment Battery
A completed clinical trial evaluating feasibility and validation of a standard phenotyping assessment battery for substance use disorders, w…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Treatment Navigation for Opioid Use Disorder [NA]
A completed clinical trial evaluating treatment navigation for opioid use disorder; results posted in 2021.
-
CLINICAL_TRIALS research · 2021-07-07Clinical Trial Update: User Acceptability of a Device-Based Opioid Overdose Intervention
A completed clinical trial assessing user acceptability of a device-based intervention for opioid overdose prevention.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid [Phase 2]
A Phase 2 clinical trial investigating high dosage buprenorphine for withdrawal assistance in analgesic opioid use.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Laparoscopic Assisted Plane Block (LAPB) Trial [Phase 4]
Phase 4 trial update for Laparoscopic Assisted Plane Block (LAPB) has been terminated.
-
CLINICAL_TRIALS withdrawal · 2021-06-18Clinical Trial Update: Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder [Phase 4]
Phase 4 trial investigating anti-suicidal effects of buprenorphine in opioid use disorder was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization [Phase 4]
Phase 4 trial update on rectal acetaminophen during oocyte retrievals aimed at reducing postoperative opioid use.
-
FDA approval · 2021-06-17FDA Approved: SUBLOCADE — Supplemental Application (Indivior Inc.)
FDA approved a supplemental application for SUBLOCADE (buprenorphine) by Indivior Inc., updating/expanding its labeling for the treatment of…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse [Phase 4]
A pragmatic Phase 4 randomized trial comparing models of care for managing prescription opioid misuse in individuals with opioid use disorde…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Stimulant Oxytocin Study [Phase 2]
Phase 2 clinical trial update for a stimulant oxytocin study investigating stimulant use with co-occurring opioid use disorders; trial compl…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis [Phase 4]
Phase 4 clinical trial evaluating continuous sub-fascial bupivacaine infusion and lidocaine patches for analgesia in post-cesarean patients …